Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 USD | +0.87% | +9.07% | -81.37% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RAPT THERAPEUTICS, INC. | Bio Therapeutic Drugs | +0.87% | +9.07% | -81.37% | -78.12% | - | 162M |
- Stock Market
- Equities
- RAPT Stock
- Charts RAPT Therapeutics, Inc.
- Relative Strength Chart